Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

University at Buffalo

Neither a doctor nor a teaching hospital

Research payments

$499,620

85 payments

Through program year 2025, University at Buffalo is reported as receiving $499,620 in research payments, across 85 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $139,637 36
2024 Research $77,580 15
2023 Research $75,654 13
2022 Research $152,647 14
2021 Research $47,455 3
2020 Research $24 1
2019 Research $6,623 3

Breakdown

Who paid Research payments · program years 2019–2025
  1. Novartis Pharmaceuticals Corporation $130,325 5 payments
  2. Pramand LLC $114,135 20 payments
  3. Imperative Care, INc $63,096 6 payments
  4. Neurocrine Biosciences, Inc. $59,884 17 payments
  5. Eli Lilly and Company $48,472 15 payments
  6. Merck Sharp & Dohme Corporation $22,255 1 payment
  7. Penumbra, Inc. $20,000 1 payment
  8. Pfizer Inc. $18,794 7 payments
  9. Arrow International, Inc. $14,988 8 payments
  10. Stryker Corporation $5,200 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. A Multicenter, Single-Blind, Prospective Randomized Post-Approval Study Comparing the Safety and Effectiveness of CraniSeal Dural Sealant to DuraSeal Dural Sealant for Dural Sealing in Elective Cranial Surgery $95,188 17 payments
  2. A Randomized, Controlled, Multicenter, Open-Label Trial Comparing A Post-Discharge Care Pathway Involving Aggressive LDL-C Management With Inclisiran With Usual Care in Patients With A Recent Acute Coronary Syndrome $76,154 3 payments
  3. Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease $59,884 17 payments
  4. Prospective Comparison of Arni With Arb Given Following Stabilization in Decompensated Hfpef (Paraglide-Hfpef) $47,996 1 payment
  5. STUDY NAME:Education and Point of Care Diagnostics Increase Substance Users Initiation of HCV Care among Persons with Substance Use Disorders $22,255 1 payment
  6. Retrospective Review of the Safety and Feasibility of a Trans-radial Approach for Neuro Interventions $20,000 1 payment
  7. A Multicenter, Single-Blind, Prospective Randomized Post-Approval Study Comparing the Safety and Effectiveness ofCraniSealDural Sealant to DuraSeal Dural Sealant for Dural Sealing in Elective Cranial Surgery $18,946 3 payments
  8. A Phase 23 Interventional Safety Pharmacokinetics and Efficacy Openlabel Multicenter Singlearm Study to Investigate Orally Administered Pf07321332 Nirmatrelvirritonavir in Nonhospitalized Symptomatic Pediatric Participants With Covid19 Who Are at Risk of Progression to Severe Disease $18,794 7 payments
  9. A Prospective Multicenter Observational Single-Arm Clinical Registry to Evaluate Contemporary Manta Outcomes in Soc Tavr Procedures $14,988 8 payments
  10. A Phase 2, Parallel-Group, Double-Blind Study to Investigate Weight Management With Ly3841136 Compared With Placebo in Adult Participants With Obesity Or Overweight $13,492 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record